Dr. Hauser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12901 Bruce B Downs Blvd
Tampa, FL 33612Phone+1 813-844-4455Fax+1 813-844-4456
Summary
- Dr. Robert Hauser is Director of the Parkinson's Disease and Movement Disorders Center of the University of South Florida. He received his medical degree from Temple University School of Medicine and has been in practice 31 years. He specializes in Parkinson's disease and is an expert in clinical research to develop new treatments for Parkinson's disease and related disorders. He also performs Botox injections for cervical dystonia, blepharospasm, and hemifacial spasm. He has published over 300 peer reviewed articles and lectures frequently at scientific meetings.
Education & Training
- Eastern Virginia Medical SchoolResidency, Neurology, 1983 - 1988
- Albert Einstein Medical CenterInternship, Transitional Year, 1982 - 1983
- Lewis Katz School of Medicine at Temple UniversityClass of 1982
Certifications & Licensure
- FL State Medical License 1989 - 2026
- CA State Medical License 1986 - 1992
- MI State Medical License 1988 - 1990
- PA State Medical License 1988 - 1990
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly
Clinical Trials
- Keppra for Cervical Dystonia Start of enrollment: 2005 Nov 01
- Study of the Application of Magnetic Fields for the Treatment of Parkinson's Disease Start of enrollment: 2009 Mar 01
- Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression Start of enrollment: 2010 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 44 citationsEvaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s diseaseRobert A. Hauser, Jarosław Sławek, Paolo Barone, Elisabeth Dohin, Erwin Surmann
BMC Neurology. 2016-06-07 - 68 citationsRandomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease.Robert A. Hauser, Anthony H.V. Schapira, Olivier Rascol, Paolo Barone, Yoshikuni Mizuno
Movement Disorders. 2010-11-15 - 13 citationsAmantadine ER (Gocovri®) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's Disease.Robert A. Hauser, Ryan R. Walsh, Rajesh Pahwa, Dustin Chernick, Andrea E. Formella
Frontiers in Neurology. 2021-03-26
Journal Articles
- Therapeutic Strategies for Parkinson Disease: Beyond Dopaminergic DrugsRobert Hauser, MD, Nature
- Deutetrabenazine for Treatment of Involuntary Movements in Patients with Tardive Dyskinesia (AIM-TD): A Double-Blind, Randomised, Placebo-Controlled, Phase 3 TrialHubert H Fernandez, Robert A Hauser, The Lancet
Press Mentions
- FDA Approves Vyalev for Advanced Parkinson's DiseaseOctober 23rd, 2024
- FDA OKs Novel Levodopa-Based Continuous Sub-Q Regimen for Parkinson’s DiseaseOctober 22nd, 2024
- Injectable Drug to Ease Advanced Parkinson's Disease Symptoms Approved by FDAOctober 17th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: